NeoDynamics AB (publ)
21 Oct - 19 Nov 2020Directed issue
NeoDynamics AB (publ) is a Swedish medtech company focused on develop diagnosis and treatment of cancer. The company has an innovative biopsy system, NeoNavia, which is built on a patented pulsing technique based on research from Karolinska Institutet.
The system is designed to provide doctors and patients a precise and credible biopsy with a great exchange for a correct diagnosis and individualized treatment. NeoNavia is being evaluated by leading clinics in Great Britain, Germany and Sweden. A commercial launch is planned to take place during 2020.
Read more on the company's website
The offer in summary
Share capital increase: Approximately 90 MSEK
Number of shares: 24 243 641
Subscription price: 3.71 SEK
Sole Manager och Bookrunner: Stockholm Corporate Finance AB